Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan.
Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan.
Heart Rhythm. 2019 Apr;16(4):544-550. doi: 10.1016/j.hrthm.2018.10.025. Epub 2018 Oct 24.
In patients with implantable cardioverter-defibrillator (ICD), ventricular tachycardia (VT) can occur spontaneously or as a result of antitachycardia pacing (ATP) that changes, rather than terminates, a spontaneous VT to a different VT. The relevance of ATP-induced VTs is uncertain.
The purpose of this study was to assess the clinical relevance of ATP-mediated VTs in patients undergoing VT ablation procedures.
Stored ICD electrograms of 162 consecutive patients with prior myocardial infarction referred for VT ablation (mean age 67.5 ± 9.2 years; 150 men; median ejection fraction 25% [IQR 20%-35%]) were reviewed. Clinical VTs were classified as spontaneous or ATP-induced. All VTs were targeted during the ablation procedures.
Of 554 ICD-recorded clinical VTs, 157 (28%) were ATP-induced (63 patients) and 397 (72%) were spontaneous. ATP-induced VTs were faster (cycle length 316 ± 62 ms vs 369 ± 83 ms; P < .001), less commonly inducible with invasive programmed stimulation (35% vs 52%; P < .001), and less commonly had identifiable target sites (21% vs 40%; P < .001) than were spontaneous VTs. During a median follow-up of 368 days [IQR: 68-1106] postablation, 71 VTs recurred (39 patients), none of which was a previously documented ATP-induced VT. A history of ATP-induced VT was associated with an increase in VT recurrence.
ATP-induced VTs occur frequently in patients with prior myocardial infarction presenting for VT ablation procedures. The presence of ATP-induced VT is associated with a higher VT recurrence rate postablation. None of the ATP-induced VTs recorded before the ablation procedure recurred postablation, and therefore ATP-induced VTs represent a marker rather than the cause of VT recurrence.
在植入式心脏复律除颤器(ICD)患者中,室性心动过速(VT)可自发发生,也可由抗心动过速起搏(ATP)引起,后者将自发 VT 转变为不同的 VT,而非终止 VT。ATP 引起的 VT 的相关性尚不确定。
本研究旨在评估在接受 VT 消融术的患者中,ATP 介导的 VT 的临床相关性。
回顾性分析了 162 例既往心肌梗死患者的 ICD 存储心电图,这些患者因 VT 消融术而被转诊(平均年龄 67.5 ± 9.2 岁;150 名男性;中位射血分数 25%[IQR 20%-35%])。临床 VT 分为自发性或 ATP 诱导性。所有 VT 均在消融过程中作为靶点。
在 554 次 ICD 记录的临床 VT 中,157 次(28%)为 ATP 诱导性(63 例),397 次(72%)为自发性。ATP 诱导性 VT 的心室率更快(周长 316 ± 62 ms 比 369 ± 83 ms;P <.001),通过侵入性程控刺激更不易诱发(35%比 52%;P <.001),且更不易确定靶点(21%比 40%;P <.001)。在消融后中位随访 368 天(IQR:68-1106)期间,71 次 VT 复发(39 例),其中无一例是先前记录的 ATP 诱导性 VT。ATP 诱导性 VT 史与 VT 复发率增加相关。
在因 VT 消融术而就诊的既往心肌梗死患者中,ATP 诱导性 VT 频繁发生。ATP 诱导性 VT 的存在与消融后 VT 复发率增加相关。在消融前记录的 ATP 诱导性 VT 无一例在消融后复发,因此 ATP 诱导性 VT 代表 VT 复发的标志物而非原因。